TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 122 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,841,000 | -79.6% | 38,605 | -71.6% | 0.19% | -64.9% |
| Q3 2021 | $9,028,000 | -14.9% | 135,900 | 0.0% | 0.55% | +24.0% |
| Q2 2021 | $10,603,000 | -17.5% | 135,900 | 0.0% | 0.44% | -17.9% |
| Q1 2021 | $12,855,000 | +51.1% | 135,900 | +94.7% | 0.54% | +18.5% |
| Q4 2020 | $8,505,000 | -17.5% | 69,800 | -40.8% | 0.45% | -34.8% |
| Q3 2020 | $10,308,000 | +35.2% | 118,000 | 0.0% | 0.70% | +17.4% |
| Q2 2020 | $7,622,000 | +44.6% | 118,000 | 0.0% | 0.59% | +74.6% |
| Q1 2020 | $5,270,000 | -28.3% | 118,000 | 0.0% | 0.34% | -3.4% |
| Q4 2019 | $7,350,000 | +65.7% | 118,000 | 0.0% | 0.35% | +77.3% |
| Q3 2019 | $4,437,000 | – | 118,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |